Stock XERS XERIS BIOPHARMA HOLDINGS, INC.
Add to a list
To use this feature you must be a member
Log inSign up

All News Xeris Biopharma Holdings, Inc.

Equities

XERS

US98422E1038

Market Closed - Nasdaq
Other stock markets
 04:00:00 2024-04-24 pm EDT 		5-day change 1st Jan Change
1.76 USD -1.12% Intraday chart for Xeris Biopharma Holdings, Inc. -1.12% -25.11%
Mar. 28 Oppenheimer Initiates Coverage on Xeris Biopharma With Outperform Rating, $5 Price Target MT
Mar. 18 Xeris Biopharma Holdings, Inc.(NasdaqGS:XERS) added to S&P Pharmaceuticals Select Industry Index CI

All News

Search
See the results
Unlock all the news on all businesses: Never miss an investment opportunity again!
100% Free Registration
Xeris Pharmaceuticals Announces Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)
BU
Xeris Biopharma to Participate in the 23rd Annual Needham Virtual Healthcare Conference
BU
Oppenheimer Initiates Coverage on Xeris Biopharma With Outperform Rating, $5 Price Target
MT
Xeris Biopharma Holdings, Inc.(NasdaqGS:XERS) added to S&P Pharmaceuticals Select Industry Index
CI
Transcript : Xeris Biopharma Holdings, Inc., Q4 2023 Earnings Call, Mar 06, 2024
Xeris Biopharma: Q4 Earnings Snapshot
AQ
Earnings Flash (XERS) XERIS BIOPHARMA HOLDINGS Reports Q4 Revenue $44.4M, vs. Street Est of $43.6M
MT
Xeris Biopharma Reports Fourth Quarter and Full Year 2023 Financial Results and Recent Events
BU
Xeris Refinances Its $150M Senior Secured Term Loan Facility With Hayfin Capital
BU
Xeris Biopharma Holdings, Inc. Reports Earnings Results for the Fourth Quarter Ended December 31, 2023
CI
Xeris Biopharma Holdings, Inc. Provides Earnings Guidance for the Year 2024
CI
Xeris Refinances its $150 Million Senior Secured Term Loan Facility with Hayfin Capital
CI
North American Morning Briefing : Stock Futures -2-
DJ
Xeris Biopharma to Report Fourth Quarter and Full Year 2023 Financial Results on March 6, 2024
BU
Xeris to Present at the Oppenheimer 34th Annual Healthcare Life Science Conference
BU
Xeris Biopharma Holdings Seeks Acquisitions
CI
Transcript : Xeris Biopharma Holdings, Inc. Presents at J.P. Morgan 42nd Annual Healthcare Conference 2024, Jan-11-2024 12:00 PM
US Equity Markets Close Higher Wednesday as Investors Await Inflation Data
MT
Sector Update: Health Care Stocks Gain Late Afternoon
MT
Xeris Biopharma Shares Rise on Licensing Agreement With Amgen
MT
No results for this search
All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Search

Announcement Date

Since

Until

  1. Stock Market
  2. Equities
  3. XERS Stock
  4. News Xeris Biopharma Holdings, Inc.